Successful treatment of Acinetobacter meningitis with meropenem and rifampicin.
Gleeson
Todd
T
Petersen
Kyle
K
Mascola
John
J
D000150:Acinetobacter / Q000472:pathogenicity*; D000151:Acinetobacter Infections / Q000188:drug therapy*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000382:microbiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy*; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000601:surgery; D013845:Thienamycins / Q000627:therapeutic use*; D014696:Ventriculostomy
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem; D012293:Rifampin